IDH1 and central nervous system cancer: However, WHO grade (HR= 2.062; p<0.0001), histological subtype (HR= 2.449; p<0.0001), and IDH Status (HR= 1.526; p= 0.001) were independent of worse prognosis biomarkers in both glioma cohorts (Figures 9A, B).